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Abstract
By stimulating collagen synthesis and myofibroblasts differentiation, transforming growth factor-b (TGF- b) plays a pivotal
role in tissue repair and fibrosis. The early growth response-1 (Egr-1) transcription factor mediates profibrotic TGF-b
responses, and its expression is elevated in biopsies from patients with scleroderma. NGF1-A-binding protein 2 (Nab2) is a
conserved transcriptional cofactor that directly binds to Egr-1 and positively or negatively modulates Egr-1 target gene
transcription. Despite the recognized importance of Nab2 in governing the intensity of Egr-1-dependent responses, the
regulation and function of Nab2 in the context of fibrotic TGF-b signaling is unknown. Here we show that TGF-b caused a
time-dependent stimulation of Nab2 protein and mRNA in normal fibroblasts. Ectopic expression of Nab2 in these cells
blocked Egr-1-dependent transcriptional responses, and abrogated TGF-b-induced stimulation of collagen synthesis and
myofibroblasts differentiation. These inhibitory effects of Nab2 involved recruitment of the NuRD chromatin remodeling
complex to the COL1A2 promoter and were accompanied by reduced histone H4 acetylation. Mice with targeted deletion of
Nab2 displayed increased collagen accumulation in the dermis, and genetic or siRNA-mediated loss of Nab2 in fibroblasts
was associated with constitutively elevated collagen synthesis and accentuation of Egr-1-dependent TGF-b responses in
vitro. Expression of Nab2 was markedly up-regulated in skin biopsies from patients with scleroderma, and was localized
primarily to epidermal keratinocytes. In contrast, little Nab2 could be detected in dermal fibroblasts. These results identify
Nab2 as a novel endogenous negative regulator of Egr-1-dependent TGF-b signaling responsible for setting the intensity of
fibrotic responses. Defective Nab2 expression or function in dermal fibroblasts might play a role in persistent fibrotic
responses in scleroderma.
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Introduction
Scleroderma is characterized by autoimmunity, vascular injury
and tissue fibrosis [1,2]. Fibroblast activation resulting in collagen
overproduction and myofibroblasts differentiation plays a central
role in the development and progression of tissue fibrosis in the skin
and internal organs. The multifunctional cytokine transforming
growth factor-b (TGF-b) is a potent stimulus for fibroblast
activation, and is strongly implicated in the pathogenesis of
scleroderma [3,4]. While both the canonical Smad pathway and
Smad-independent signaling cascades have been shown to mediate
intracellular TGF- b signaling, the molecular mechanisms regulat-
ing fibrotic TGF-b responses remain incompletely understood [5].
Identification and functional characterization of the transcription
factors and cofactors that mediate TGF-b responses has significant
implications for the development of anti-fibrotic therapies [6].
The early growth response family of zinc finger transcription
factors includes Egr-1 (also known as NGFI-A), Egr-2, Egr-3 and
Egr-4 [7,8,9]. Members of the Egr-1 family are implicated in the
regulation of cell growth, differentiation and apoptosis. Although
most normal cells show negligible basal expression of Egr-1,
synthesis is induced in a rapid and generally transient manner by a
variety of extracellular signals generated during stress and injury.
Stimuli for Egr-1 expression include growth factors, hypoxia,
reactive oxygen species, ultraviolet light and mechanical injury.
We demonstrated previously that TGF-b was an additional
stimulus for inducing Egr-1 expression in normal fibroblasts
[10]. The response involved a Smad-independent signal trans-
duction pathway with sequential activation of MEK1, ERK1/2
and Elk-1, as well as the non-receptor protein kinase c-Abl [11,12].
Ectopic Egr-1 was sufficient for stimulating collagen gene
expression in the absence of TGF-b. We demonstrated that levels
of Egr-1 were markedly elevated in mice with bleomycin-induced
scleroderma (10). Moreover, the expression of Egr-1 was found to
be enhanced in skin and lung biopsies from patients with
scleroderma [10,11]. Together, these observations point to a
hitherto unrecognized fundamental role for Egr-1 in the
pathogenesis of fibrosis in mouse and man.
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tightly regulated. One of the factors implicated in regulation of
Egr-1 is NGF1-A-binding protein 2 (Nab2), a 55 kD nuclear
protein originally identified based on its ability to interact with
Egr-1 and inhibit its transcriptional activity [13,14]. Subsequent
studies revealed that Nab2 lacks DNA-binding activity, but can
positively or negatively modulate the expression of Egr-1 target
genes via direct interaction with Egr-1 [15]. Nab2 shares
conserved N-terminal NCD1 (Egr-1 interaction) and C-terminal
NCD2 (transcriptional regulation) domains with another Egr-1
binding protein called Nab1. However, while Nab2 is an inducible
modulator of transcription, Nab1 is constitutively expressed in
most tissues, and functions as general transcriptional regulator
[16]. The synthesis of Nab2 is stimulated by some of the same
signals that also induce Egr-1, suggesting that Nab2 might function
in a negative feedback for Egr-1 activity [14]. Although Nab2 has
been implicated in macrophage development, cardiac hypertro-
phy, peripheral neuropathy and prostate cancer, to date its in vivo
functions are poorly understood. Mice with targeted deletion of
Nab2 showed no obvious phenotype [17]. In contrast, mice
lacking both Nab1 and Nab2 showed profound hypomyelination
and died at an early age [17].
Despite the potentially important role of Nab2 in modulating
Egr-1 activity and target gene expression, its regulation remains
incompletely understood. Furthermore, the expression and
function of Nab2 in the context of physiologic and pathological
fibrogenesis are unknown. Here we show that TGF-b stimulates
the expression of Nab2 in normal skin and lung fibroblasts. The
Nab2 response is slightly delayed compared to Egr-1, and involves
a Smad-independent MAP kinase intracellular signaling cascade.
Ectopic Nab2 blocked Egr-1-dependent transcriptional responses,
and prevented the stimulation of collagen synthesis and myofi-
broblasts differentiation. These inhibitory effects of Nab2 were
accompanied by recruitment of the histone deacetylase HDAC1
and attenuated histone H4 hyperacetylation at the COL1A2
promoter. Mice null for Nab2 showed increased accumulation of
collagen in the skin. Genetic or siRNA-mediated repression of
Nab2 in fibroblasts was associated with constitutive Egr-1 activity,
increased collagen synthesis, and enhancement of Egr-1-depen-
dent TGF-b responses in vitro. Skin biopsies from patients with
scleroderma were characterized by markedly elevated Nab2
expression, localized primarily in the nuclei of epidermal
keratinocytes and cells lining dermal appendages. In contrast,
fibroblasts in the lesional skin had only scant Nab2 expression.
These results demonstrate, for the first time, that Nab2 functions
as an inducible inhibitor of Egr-1-mediated TGF-b signaling, and
has an important physiologic role in modulating the intensity or
duration of fibrotic responses. Impaired Nab2 expression or
function might contribute directly to the development or
progression of fibrosis in scleroderma.
Materials and Methods
Cell culture and reagents
Primary cultures of dermal fibroblasts were established by
explantation from neonatal foreskin, and studied at early (,8)
passage [18]. Mouse NIH3T3 fibroblasts were obtained from the
American Type Culture Collection (Mansassas, VA). Fibroblasts
were established from Nab2
2/2 mice and wildtype littermate
embryos and studied in parallel. Fibroblast cultures were
maintained in modified Eagle’s medium (EMEM) or Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (FCS) (Gibco BRL, Grand Island, NY), 1% vitamin
solutions, and 2 mM L-glutamine. Normal human lung fibroblasts
(NHLF) were obtained from Clonetics (CC-2512, Cambrex,
Walkersville, MD) and maintained in FGMH-2 media (CC-3132)
(Cambrex). All other tissue culture reagents were from Biowhit-
taker (Walkersville, MD). For experiments, cultures were placed in
fresh serum-free media containing 0.1% bovine serum albumin
(BSA) for 24 h prior to addition of indicated concentrations of
TGF-b1 (PeproTech, Rocky Hill, NJ).
Real-time quantitative PCR
At the end of the experiments, total RNA was isolated from
fibroblasts and reverse-transcribed to cDNA using Reverse
Transcription System (Promega, Madison, WI) [11]. The products
(50 ng) were amplified using SYBR Green PCR Master Mix
(Applied Biosytems, Foster City, CA) with primers (shown in
Table 1) on the Applied Biosystems 7500 Prism Sequence
Detection System. Tissue mRNA levels were determined by
real-time quantitative PCR [19]. Total RNA was isolated from
skin tissue using Trizol Reagent (Invitrogen, Carlsbad, CA),
purified and reverse transcribed, followed by real-time qPCR.
Western Analysis
At the end of the experiments, cultures were harvested. Equal
amounts of whole cell lysate proteins (20–50 mg/lane) were
Table 1. Oligonucleotides used for Real-Time Quantitative
PCR.
Human
Egr-1 Forward: 59-TGCGGCAGAAGGACAAGAAAGC-39
Reverse: 59-TGAGGAAGGGAAGCTGCTGACC-39
COL1A1 Forward: 59- CCAGAAGAACTGGTACATCAGCA-39
Reverse: 59- CGCCATACTCGAACTGGGAAT-59
COL1A2 Forward: 59- GATGTTGAACTTGTTGCTGAGG-39
Reverse: 59- TCTTTCCCCATTCATTTGTCTT-39
CTGF Forward: 59- TTGCGAAGCTGACCTGGAAGAGAA-39
Reverse: 59- AGCTCGGTATGTCTTCATGCTGGT-39
Nab2 Forward: 59-TGACAGCCAGAAGGAAGAGGA-39
Reverse: 59-AGGTGCTCTCTCTCGGGCTACTT-39
Actin Forward: 59-AATGTCGCGGAGGACTTTGAT-39
Reverse: 59-AGGATGGCAAGGGACTTCCTG-39
Mouse
COL1A1 Forward: 59- CCTGAGTCAGCAGATTGAGAA-39
Reverse:59ACTGAACTTGACCGTACACCAGTACTCTCCGCTCTTCAA-39
COL1A2 Forward: 59-CCGTGCTTCTCAGAACATCA-39
Reverse: 59-CTTGCCCCATTCATTTGTCT-39
GAPDH Forward: 59-GTCGTGGATCTGACGTGCC-39
Reverse: 39-GATGCCTGCTT CACCACCTT-39
Egr-1 Forward: 59-TTTGCCTCCGTTCCACCTGC-39
Reverse: 59-TGCCAACTTGATGGTCAT GCGC-39
Nab2 Forward: 59-GAGGAGGGGTTGCTGGACCG-39
Reverse: 59- GGCTGGAGGCAAAGTCCG-39
aSMA Forward: 59-CAGCGGGCATCCACGAA-39
Reverse: 59-GCCACCGATCCAGACAGA-39
18s rRNA Forward: 59-TTCGAACGTCTGCCCTATCA-39
Reverse: 59-ATGGTAGGCACGGCGACTA -39
doi:10.1371/journal.pone.0007620.t001
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polyacrylamide gradient gels [11]. Proteins were transferred to
Immobilon-P membranes (Millipore, Billerica, MA), and mem-
branes were probed sequentially with primary antibodies specific
for Type I collagen (Southern Biotechnology, Birmingham, AL),
Nab2 (IC4, C6), Egr-1 (C19), tubulin (Sigma-Aldrich, St. Louis,
MO), actin (C2) (all from Santa Cruz Biotechnology, Santa Cruz,
CA) or phospho-Smad2 (Ser
465,467) and Smad2 (both from Cell
Signaling, Beverly, MA). Membranes were then incubated with
appropriate secondary antibodies and subjected to enhanced
chemiluminescence detection using ECL Reagent (Amersham-
Pharmacia, Piscataway, NJ).
Immunoprecipitation- immunoblot analysist
Equal aliquots of whole cell lysates were immunoprecipitated
using antibodies against Egr-1 (588, Santa Cruz). Immunoprecip-
itated proteins were subjected to Western analysis as above, using
primary antibodies specific for HDAC1 (C19) or Nab2 (IC4) (both
from Santa Cruz).
Transient Transfection Assays
The reporter constructs 772COL1A2-CAT harboring the
2772/+58 bp fragment of the human proa2(I) collagen gene
[20], 376COL1A2-luc harboring [21] and pEBS4-luc harboring
four copies of the minimal Egr-1 responsive element (EBS) linked
to luciferase [22] were used for transient transfection assays.
Subconfluent cultures of human foreskin or mouse NIH3T3
fibroblasts in serum-free media were transfected using Superfect
reagent (Qiagen, Valencia, CA). Following 24 h incubation with
TGF-b1, cultures were harvested, and whole cell lysates were
prepared and assayed for their CAT or luciferase activities [23]. In
each experiment, fibroblasts were cotransfected with Renilla
luciferase pRL-TK plasmids (Promega) as a control for transfec-
tion efficiency. Experiments were performed in triplicates and
repeated at least twice.
Infection with adenovirus and siRNA knockdown
experiments
Adenoviral recombinants containing wildtype Egr-1 (Ad-Egr-1),
or a constitutively active mutant Egr-1 (Ad-mEgr-1), EGFP (Ad-
EGFP), and NAB2 (Ad-Nab2) co-expressing the green fluorescent
protein (GFP) [24] were amplified. Confluent human skin
fibroblasts in serum-free media were infected with adenovirus.
After 24h of incubation, fresh media with 10% FBS were added,
and 24 h later whole cell lysates or total RNA were harvested for
analysis.
To deplete cellular Nab2 skin fibroblasts were transfected with a
Nab2-specific siRNA or an irrelevant negative control siRNA
(Applied Biosystems/Ambion, Austin, TX) using Lipofectamine
TM
RNAiMAX (Invitrogen, Carlsbad, CA) transfection reagent
following manufacture’s protocol. Forty eight hour later, fibro-
blasts were incubated with TGF-b1 for a further 24 h. At the end
of incubation cells were harvested, and whole cell lysates or total
RNA were analysed. Knockdown efficiency was evaluated by
determining the levels of Nab2 protein by Western analysis.
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were per-
formed using Ez-Magna CHIP
TM G (Millipore, Billerica, MA) as
described [12]. Briefly, confluent cultures of fibroblasts transfected
with Nab2 or empty vector were incubated with TGF-b1 (10 ng/
ml) for 120 min or 24 h. Formaldehyde (final concentration 1%)
was added to the cultures to cross-link chromatin. Nuclear extracts
were then prepared and sonicated on ice to generate chromatin
DNA fragments with an average length of 500–1000 bp. Aliquots
of lysates were immunoprecipitated with antibodies to CHD3/4
(sc-11378), HDAC1 (C9), Nab2 (IC4) or Egr-1 (588) (all from
Santa Cruz), or acetylated histone H4 (Upstate/Millipore, Billerica,
MA). DNA was recovered, and PCR amplification of the cap-
tured sequences was performed using primers complementary
to the COL1A2 promoter region harboring both of the putative
Egr-1-binding sites [10]. The primer sequences were forward
primer, 59-CTACAGGGCACAGGTGAGG- 39, and reverse prim-
er, 59-AAAGCCCGGATCTGCCCTA-39, to generate a 422-bp
amplification product. DNA samples were analyzed by electropho-
resis in 2% agarose gels stained with ethidium bromide. Input
samples were used as controls.
Immunofluorescence microscopy
Foreskin fibroblasts seeded in 12-well plates (10
4 cells/well) were
transfected with Nab2 plasmids, followed by incubation in serum-
free media with TGF-b1 for indicated periods. Cultures were then
fixed and permeabilized with paraformaldehyde and 100%
methanol, and incubated with antibodies to Nab2 (Santa Cruz)
or to Type I collagen (Southern Biotechnology) at a 1:100 dilution,
followed by Alexa-fluor secondary antibodies (Invitrogen). Nuclei
were identified using 4,6-diamidino-2-phenylindone (DAPI).
Subcellular distribution of immunofluorescence was then evaluat-
ed using a Nikon Eclipse TE200 microscope (Fryer Company, IL).
Acetylated histone H4 (Ac-H4) and HDAC1 expression was
further examined by fluorescence confocal microscopy as above
[11]. Cultures were incubated with anti rabbit human Ac-H4
(Upstate) or HDAC1 (Santa Cruz) antibodies at a 1:100 dilution,
followed by FITC-labeled secondary antibodies (Promega). For
tissue immunofluorescence, the deparafinized sections were
subjected to antigen retrieval followed by incubation with anti
mouse aSMA (Sigma-Aldrich) at 1:200 dilution for 1 hour at room
temperature followed by Alexa-fluor-labeled secondary antibodies
(Invitrogen). Slides were mounted and subcellular distribution of
immunofluorescence was then evaluated under a Zeiss UV Meta
510 confocal microscope (Carl Zeiss Inc, Jena, Germany).
Immunohistochemistry
Samples were obtained by skin biopsy from the affected forearm
from six patients with scleroderma, and from the forearm of three
healthy adults. The protocols for tissue collection were approved
by the Institutional Review Boards for Human Studies at
Northwestern University and Kanazawa University. Four mm
thick paraffin-embedded skin sections were deparaffinized,
rehydrated and immersed in TBS-T buffer (Tris-buffered saline-
0.1%Tween 20) followed by target retrieval solution (DAKO,
Carpinteria, CA). Following incubation of the slides using primary
antibodies against anti-mouse Nab2 monoclonal antibodies (Santa
Cruz, 1:50 dilution), anti-rabbit phospho-Smad2 (Cell Signaling
Technology, 1:100 dilution), and anti-rabbit Egr-1 (Santa Cruz,
1:100 dilution), appropriate goat anti-mouse IgG or donkey anti
goat IgG (Dako) were applied as secondary antibodies. Bound
antibodies were detected using DAKO Envision + System
according to the manufacturer’s instructions. phospho-Smad2
(Cell Signaling Technology, Danvers, MA), After counterstaining
with hematoxylin, sections were mounted with Permount (Fisher
Scientific, Pittsburgh, PA) and viewed under Zeiss Axioskop
Upright Microscope with CRi spectral CCD camera (Carl Zeiss
Inc, Jena, Germany). Substitution of primary antibody with non-
specific mouse IgG served as negative control.
Skinwas also harvested from six month-old Nab2 null (Nab2
2/2)
mice and C57BL/6 isogenic controls (17). Four mm thick sections of
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eosin (H&E). To analyze the collagen content and architecture in
thelesional skin, deparafinizedsections were stained with Picrosirius
red and viewed under polarized light [19].
Statistical Analysis
Statistical significance was determined using the unpaired
Student’s t-test. A p value ,0.05 was considered significant.
Results
TGF-b stimulates Nab2 expression in normal skin and
lung fibroblasts
We have shown previously that TGF-b stimulated the
expression of Egr-1 in normal fibroblasts [10,11]. Furthermore,
ectopic expression of Egr-1 was sufficient to stimulate collagen
synthesis in these cells. These finding suggested a novel role for
Egr-1 in mediating profibrotic TGF-b responses. We hypothesized
that as an endogenous cofactor for Egr-1, Nab2 might be involved
in modulating TGF-b responses. To begin to explore the function
of Nab2 in fibroblasts biology and TGF-b signaling, we first
examined the regulation of Nab2 by TGF-b. Compared to the
rapid and transient increase in Egr-1 mRNA expression that was
induced by TGF-b, Nab2 showed a comparatively delayed
stimulatory response that persisted even after 24 h in normal skin
and lung fibroblasts (Fig. 1 and data not shown). Western analysis
demonstrated rapid accumulation of Egr-1 protein that peaked at
60 min of TGF-b1 incubation, whereas the Nab2 response in the
same cells peaked later at 240 min. Immunofluorescence studies
showed a time-dependent progressive increase in Nab2 within the
nucleus, indicating that enhanced synthesis of Nab2 was
accompanied by its nuclear translocation in TGF-b1-treated
fibroblasts (Fig. 1C). The stimulation of Nab2 expression by TGF-
b1 was completely abolished by pretreatment of the cultures with
the MEK1 inhibitor U0126, whereas the ALK5 inhibitor
SB431542 did not significantly affect the response (Fig. 1D).
Nab2 blocks Egr-1-dependent transcriptional activity
To examine the modulation of Egr-1-dependent responses by
Nab2 in the context of fibrogenesis, confluent NIH3T3 fibroblasts
were transfected with adenovirus for Egr-1 (Ad-Egr-1), or a
mutant Egr-1 (Ad-Egr-1m) that is resistant to Nab2 due to a
mutation in the Nab2-binding repression domain [24]. The
fibroblasts were then cotransfected with pEBS4-luc, a synthetic
promoter-luciferase reporter construct containing four canonical
Egr-1 binding sites, and incubated for an additional 24 h. The
results of transient transfection assays showed that ectopic Nab2
completely blocked the stimulation of pEBS4-luc activity induced
by wildtype Egr-1, as shown previously [25], whereas stimulation
induced by the Nab2-resistant mutant Egr-1 was unaffected (data
not shown).
Nab2 abrogates TGF-b-induced stimulation of Type I
collagen synthesis and myofibroblast differentiation
We had suggested previously that endogenous Egr-1 plays an
important role in mediating TGF-b responses [10], prompting us
to consider therefore whether Nab2 might function as a negative
regulator of TGF-b signaling. To investigate the modulation of
TGF-b-induced transcriptional activation, fibroblasts were trans-
fected with Nab2, and incubated in the presence and absence of
TGF-b. The results showed that ectopic Nab2 abrogated TGF-b-
induced stimulation of collagen synthesis in mouse (Fig. 2A) and
human fibroblasts (Fig. 2B). In addition, stimulation of Egr-1-
dependent transcription (pEBS4-luc) by TGF-b was also abrogated
(data not shown). Moreover, ectopic Nab2 also abrogated TGF-b-
induced stimulation of Type I collagen synthesis, COL1A2
Figure 1. TGF-b stimulates Nab2 expression. Confluent cultures of human foreskin fibroblasts were incubated with TGF-b1 (10 ng/ml) for
indicated periods. A, D Total RNA was isolated and analysed by real-time quantitative PCR. Results, normalized with actin, are the means6S.D. of
triplicate determinations from a representative experiment. B. Whole cell lysates were subjected to Western analysis. Representative immunoblots. C.
Fibroblasts were fixed and stained with anti-Nab2 antibodies, or DAPI to detect nuclei, and viewed by immunofluorescence microscopy (original
magnification 6100).
doi:10.1371/journal.pone.0007620.g001
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in human skin and lung fibroblasts (Figs. 2C and D).
Myofibroblasts play a central role in the development and
progression of tissue fibrosis. Because TGF-b stimulates myofi-
broblasts differentiation, and as myofibroblasts accumulation was
found to be attenuated in Egr-1 null mice [26]. we investigated the
regulation of myofibroblast differentiation by Nab2. For this
purpose, fibroblasts were transfected with Nab2, and following
incubation with TGF-b for 48 h, examined by immunofluores-
cence. The results showed that whereas TGF-b induced a marked
increase in a-SMA expression and stress fiber incorporation in
transfected fibroblasts, ectopic Nab2 abolished this stimulatory
response (Fig. 2E). Induction of Smad2 phosphorylation, a specific
marker for canonical TGF-b signaling, was unaffected by ectopic
Nab2 (data not shown). Together, these results demonstrate that
Nab2 has potent inhibitory effect on TGF-b-driven stimulation of
fibrotic responses independent of canonical Smad signaling. We
speculated that these inhibitory effects of Nab2 involved repression
of TGF-b-induced Egr-1 signaling. To explore this possibility,
additional transient transfection assays were performed. The
results showed that ectopic expression of Nab2 blocked the
stimulation of COL1A2-luc activity and Type I collagen synthesis
induced by Egr-1 (Figs. 3A and B, and data not shown), whereas
stimulation induced by the Nab2-resistant mutant Egr-1 could not
be prevented by Nab2. Taken together, these results not only
confirm that the inhibitory effect of Nab2 was selective for Egr-1-
dependent transcriptional responses, but also serve to further
underline the essential role of endogenous Egr-1 in mediating the
stimulation of collagen gene expression and myofibroblasts
differentiation induced by TGF-b.
To investigate the role that endogenous Nab2 might play in the
physiologic regulation of collagen gene expression, two comple-
mentary approaches were taken. First, mouse embryonic fibro-
blasts (MEFs) were generated from Nab2-null mice and studied in
vitro. Whereas Nab2
2/2 MEFs in vitro displayed morphology and
proliferation rates indistinguishable from wildtype MEFs under
Figure 2. Nab2 abrogates TGF-b responses. Cultures of fibroblasts were cotransfected with Nab2 expression vectors or empty vector and
harvested following incubation with TGF-b1 for 24 or 48 h. A. Whole cell lysates were examined by Western analysis. Representative immunoblots. B.
Fibroblasts were fixed, incubated with antibodies to Type I collagen, and examined by immunofluorescence microscopy (original magnification
6400). Nuclei were identified by DAPI (blue). C. Total RNA was isolated and examined by real-time qPCR. Results, normalized with actin, are the
means6S.D. of triplicate determinations from a representative experiment. D. Fibroblasts were cotransfected with 772COL1A2-CAT. Cell lysates were
assayed for their CAT activities (upper panels) or examined by Western analysis (lower panels). Results of CAT assays, normalized with Renilla
luciferase, are expressed as means6S.D. of triplicate determinations from a representative experiment. Open boxes, untreated fibroblasts; closed
boxes, TGF-b-treated fibroblasts. *p,0.005. E. After 48 h fibroblasts were fixed, incubated with antibodies to a-SMA (green) and examined by
immunofluorescence microscopy. Nuclei were identified by DAPI (blue). Representative images (original magnification 6100).
doi:10.1371/journal.pone.0007620.g002
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in their biosynthetic phenotypes were evident. Western analysis
and real-time qPCR revealed substantial increases in the
constitutive rate of collagen synthesis, and in COL1A1 and
COL1A2 mRNA expression in Nab2
2/2 MEFs compared to
wildtype MEFs cultured in parallel (Figs. 4A and B). Furthermore,
incubation of Nab2
2/2 MEFs with TGF-b resulted in further
enhancement of collagen gene expression. A potential mechanistic
explanation to account for the enhanced collagen gene transcrip-
tion seen in Nab2
2/2 MEFs was provided by the finding that the
basal activity of the Egr-1-responsive reporter pEBS4-luc was
constitutively elevated in Nab2
2/2 MEFs, and could be partially
normalized by rescuing these cells with ectopic Nab2 (Fig. 4C).
These results suggest the basal Egr-1 activity is unopposed in
Nab2
2/2 MEFs. Next, we used an siRNA knockdown approach
to reduce cellular Nab2 expression. Transfection of normal dermal
fibroblasts with a Nab2 siRNA reduced the baseline levels of
Nab2, and abrogated the stimulation of Nab2 expression by TGF-
b (Fig. 4D). Transfection of an irrelevant negative control siRNA
(lanes 1,2) had no effect on Nab2 expression. The inhibitory effect
of the siRNA was specific for Nab2, since levels of tubulin were
unaffected. Down-regulation of cellular Nab2 was accompanied
by significantly enhanced stimulation of collagen gene expression
in response to TGF-b (Fig. 4D, right panel). Together, the results
of these complementary genetic and siRNA-mediated loss-of-
function experiments point to an important physiologic function of
cellular Nab2 in negative modulation of basal and TGF-b-induced
collagen gene expression.
Nab2 negatively regulates dermal collagen accumulation
in vivo
To further investigate the role of Nab2 in the regulation of
extracellular matrix homeostasis, skin from six-months old
Nab2
2/2 mice and wildtype littermates was harvested. Mice
deficient in Nab2 were produced at the expected mendelian ratios
and showed no overt phenotype at this age [17]. Histological
examination of skin biopsies stained with hematoxylin and eosin
showed that Nab2
2/2 mice had a more compact and sclerotic
dermis than wildtype controls (Fig. 5A, a–d). The striking
epidermal hyperkeratinization previously described in mice
lacking both Nab1 and Nab2 (17) was not seen. To evaluate the
collagen content and architecture of the skin, deparafinized
sections were stained with Picrosirius red and viewed under
polarized light. Increased dermal accumulation of strongly red
birefringent collagen fibers was noted in Nab2
2/2 mice compared
to wildtype littermates (Fig. 5A, panels e,f). Immunofluorescence
showed increased numbers of a-smooth muscle actin-positive
myofibroblasts in the dermis from Nab2
2/2 mice (Fig. 5B,
compare panels c and f). Furthermore, mRNA levels for COL1A1,
COL1A2 and a-smooth muscle actin were also significantly
increased in the skin of Nab2
2/2 mice (Fig. 5C).
Nab2 recruits NuRD complex to the COL1A2 promoter
and attenuates histone H4-hyperacetylation
Previous studies showed that Nab2 can interact with the
nucleosomal remodeling and deacetylation (NuRD) complex that
comprises histone deacetylase HDAC1/2 and CHD4
[27,28,29,30,31,32]. To begin to explore the mechanistic basis
for the repression of TGF-b responses in the presence of ectopic
Nab2, cell lysates were prepared from fibroblasts harboring
ectopic Nab2 that had been exposed to TGF-b. The lysates were
immunoprecipitated with antibodies to Egr-1, and immunoblotted
with antibodies to HDAC1. The results showed low levels of
constitutive interaction between cellular Egr-1 and HDAC1 in
unstimulated fibroblasts (Fig. 6A). The interaction was consider-
ably enhanced in Nab2-transfected fibroblasts in the absence, and
even more so in the presence, of exogenous TGF-b. Western
analysis of the same whole cell lysates showed that ectopic Nab2
completely abrogated TGF-b-induced stimulation of Type I
collagen synthesis, as expected (data not shown).
These results suggested that ectopic overexpression of Nab2
exerted a stimulatory effect enhancing the interaction of cellular
Egr-1 with HDAC1. To investigate the role of Egr-1 in the
abrogation of TGF-b-induced fibroblast responses by ectopic
Nab2, chromatin immunoprecipitation (ChIP) assays were per-
formed. For this purpose, fibroblasts expressing ectopic Nab2 were
incubated with TGF-b for indicated periods. Following formalde-
hyde cross-linking, chromatin was isolated and subjected to ChIP
Figure 3. Nab2 blocks Egr-1-dependent collagen stimulation. A. Foreskin fibroblasts were cotransfected with expression vector for wildtype
or mutant Egr-1 along with Nab2 or empty vector, and 376COL1A2-luc_reporter constructs. Following incubation of cultures for 24 h, cell lysates
were prepared and assayed for their luciferase activities. Results, normalized with Renilla luciferase, are expressed as means6S.D. of triplicate
determinations. *p,0.005. B. Foreskin fibroblasts were infected with Ad-Egr-1m along with Ad-Nab2. Following 24 h incubation, whole cell lysates
were prepared and subjected to Western analysis. Representative immunoblots.
doi:10.1371/journal.pone.0007620.g003
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amounts of COL1A2 promoter associated with HDAC1could be
detected in fibroblasts harboring empty vector, ectopic Nab2
expression was accompanied by increased accumulation HDAC1,
as well as Nab2, on the Egr-1-binding region of COL1A2
promoter fragments (Fig. 6B). Accumulation of CHD4, another
member of the NuRD complex, was also enhanced by TGF-b,
and was markedly elevated in Nab2-transfected fibroblasts. In
contrast, TGF-b-induced histone H4 hyperacetylation at the
COL1A2 locus was markedly attenuated in the presence of ectopic
Nab2. Increased nuclear levels of HDAC1 in fibroblasts harboring
ectopic Nab2, and attenuation of histone H4 hyperacetylation,
were confirmed by immunofluorescence confocal imaging
(Fig. 6C). Together, these results suggest that ectopic Nab2
expression in fibroblasts stimulated the recruitment of HDAC1
and CHD4, with ensuing decrease in histone hyperacetylation at
the COL1A2 promoter.
Based on these results, we surmised that NuRD complex
recruitment to the COL1A2 promoter may play a role in repression
of the stimulation of collagen gene expression in the presence of
ectopic Nab2. This notion was explored by disrupting NuRD
function. For this purpose, transient transfection assays were
performed in the presence of wildtype CHD4 or CHD4del
(1–1280),
a dominantnegativeCHD4mutantthatbindstoNab2butlacksthe
ATPase domain required for nucleosome remodeling [27]. The
results of transfection assays showed that ectopic Nab2 prevented
the stimulation of Egr-1-dependent transcription in presence of
wildtype CHD4, as expected, but it failed to block the response in
fibroblasts harboring the mutant CHD4, suggesting a critical role of
the NuRD remodeling complex in Nab2-mediated repression
(Fig. 6D). The speculative model for the proposed mechanism of
action is illustrated schematically in Fig. 6E.
Elevated Nab2 expression in scleroderma skin biopsies
We showed previously that aberrant TGF-b signaling in
scleroderma was associated with sustained up-regulation of Egr-1
expression in the lesional skin [11]. The present results revealed a
potentially important functional role for Nab2 in the regulation of
Egr-1 activity. To examine the expression of Nab2 in scleroderma,
biopsies of lesional skin from patients with scleroderma and dorsal
forearm biopsies from healthy controls were studied in parallel.
The clinical features of the patients are shown in Table 2. The
results of immunohistochemistry showed virtual absence of Nab2
healthy skin. In marked contrast, very strong and uniform Nab2
immunostaining was evident in each scleroderma skin biopsy
(Fig. 7). In these samples, Nab2 accumulation was nuclear and
primarily localized to the epidermis. In addition to keratinocytes,
dermal blood vessels, hair follicles, eccrine glands and occasional
infiltrating round cells also showed strong immunostaining. In
contrast, however, only occasional fibroblastic cells were positive
for Nab2. These were distributed throughout the dermis and
showed faint and inconsistent staining. Immunostaining was
Figure 4. Enhanced collagen stimulation in Nab2-deficient fibroblasts. Wildtype and Nab2
2/2 mouse embryonic fibroblasts (MEFs) cultured
in parallel were incubated with or without TGF-b1 for 24 h. A. Whole cell lysates and culture supernatants were subjected to Western analysis.
Representative immunoblots. B. Total RNA was subjected to real-time qPCR analysis. Results, expressed relative to 18 s, are the means6S.D. of
triplicate determinations from a representative experiment. Open boxes, untreated fibroblasts; closed boxes, TGF-b-treated fibroblasts. *p,0.005. C.
MEFs were transfected with pEBS4-luc inpresence or absence of Nab2. Following 24 h incubation, cultures were harvested and cell lysates were
assayed for their luciferase activities. The results, normalized with Renilla luciferase, are the means6S.D. of triplicate determinations. D. siRNA
knockdown. Normal dermal fibroblasts were transfected with Nab2 siRNA or irrelevant negative control siRNA, and incubated with TGF-b. Twenty-
four h later, fibroblasts were harvested. Levels of Nab2 and collagen were determined by Western analysis of whole cell lysates.
doi:10.1371/journal.pone.0007620.g004
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nonspecific mouse IgG resulted in the absence of staining (data not
shown). In the same skin biopsies, Egr-1 immunostaining was
evident in majority of dermal fibroblasts. Furthermore, most
dermal fibroblasts showed strong expression of nuclear phospho-
Smad2, indicating active TGF-b signaling in these cells.
Discussion
We recently identified Egr-1 as a novel intracellular mediator of
TGF-b responses [10]. The expression of Egr-1 was markedly up-
regulated in the fibrotic lesion in a mouse model of scleroderma, as
well as in skin and lung biopsies from patients with scleroderma
[11]. The expression and activity of Egr-1 are normally tightly
regulated through a variety of mechanisms. The present studies
focused on Nab2, a non-DNA-binding cofactor for Egr-1. The
results demonstrated that Nab2 expression was induced by TGF-
b, and ectopic Nab2 abrogated TGF-b-dependent fibrotic
responses such as stimulation of collagen gene expression and
myofibroblasts differentiation, by blocking Egr-1-dependent target
gene transcription. Mice lacking Nab2 showed evidence of
enhanced fibrogenesis in the skin, and explanted Nab2-null
fibroblasts showed constitutive Egr-1 transcriptional activity and
elevated collagen gene expression in vitro. Furthermore, repres-
sion of endogenous Nab2 using siRNA knockdown was accom-
panied by enhancement of Egr-1-dependent TGF-b responses in
normal fibroblasts. Nab2 promoted HDAC1 recruitment to the
COL1A2 promoter and abrogated histone hyperacetylation
induced by TGF-b. While Nab2 expression was dramatically up-
regulated in epithelial cells in scleroderma skin biopsies, consistent
with activated TGF-b signaling in the fibrotic milieu, dermal
fibroblasts from biopsies that were strongly immunopositive for
Egr-1 and phospho-Smad2 showed a paucity of Nab2 expression.
These findings indicate that in the context of TGF-b-induced
profibrotic responses, Nab2 functions as an important negative
regulator, and impaired Nab2 expression or function in activated
dermal fibroblasts might contribute to the persistence or
progression of skin fibrosis in scleroderma.
The expression of Egr-1 during acute injury is induced by
serum, platelet-derived growth factor (PDGF), TGF-b, hypoxia
and oxidative stress, and in turn, Egr-1 stimulates the expression of
PDGF, tissue factor and TGF-b itself [9,13,14,33,34]. Egr-1 is
Figure 5. Increased skin collagen accumulation in Nab2
2/2 mouse. Skin from Nab2
2/2 mice and wildtype mice was harvested. A. Tissues
were stained with hematoxylin and eosin (a–d) or picrosirius red (e,f). Original magnification 6100 (a, b), 6400 (c–f). B. Immunofluorescence using
antibodies to a-smooth muscle actin (green). Nuclei were identified by DAPI (blue). Original magnification6100 (a, d), 6200 (b, c, e, f). C. Total RNA
was harvested and was subjected to real-time qPCR analysis. Results, expressed relative to 18S, are the means6S.D. of triplicate determinations from
a representative experiment.
doi:10.1371/journal.pone.0007620.g005
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normal wound healing and tissue repair [26]. Like other
transcription factor, Egr-1 interacts with cofactors that can
modulate the transcription of Egr-1 target genes. Nab2, originally
identified by yeast two-hybrid assays, is a non-DNA binding
cofactor that directly interacts with a conserved 34-amino acid
Figure 6. Ectopic Nab2 recruits NuRD complex to the COL1A2 promoter. A. Foreskin fibroblasts transfected with Nab2 were incubated with
TGF-b1 for 24 h. Whole cell lysates were immunoprecipitated with antibodies against Egr-1 and immunoblotted using indicated antibodies.
Representativeimmunoblots.B. ChIP assays.Fibroblaststransfectedwith Nab2were formaldehydecross-linkedandimmunoprecipitatedwithindicated
antibodies, followed by amplification of the captured DNA using COL1A2-specific primers. Input genomic DNA was used as positive control. C.
Fibroblasts transfected with Nab2 were incubated with TGF-b for 2 h. Cells were then fixed, incubated with indicated antibodies and examined by
immunofluorescence confocal microscopy. Nuclei were identified by DAPI (blue). Representative images. Original magnification 6400. D. NIH3T3
fibroblasts were cotransfected with expression vectors for Egr-1, Nab2, wildtype CHD4 or mutant CHD4 del(1–1280) or empty vector, along with pEBS4-
luc. Cultures were harvested 24 h later, and cell lysates were assayed for their luciferase activities. The results, normalized with Renilla luciferase, are the
means6S.D. of triplicate determinations. *p,0.005. E. Cartoon illustrating the mechanism underlying modulation of collagen gene expression by Nab2.
Inunstimulatedfibroblasts(basalstate),smallamountsofEgr-1andNab2areconstitutivelyassociatedwiththeCOL1A2promoter.UpontransientTGF-b
stimulation, Egr-1 is induced and recruited to the COL1A2 promoter, where together with p300 it enhances histone H4 hyperacetylation and stimulates
transcription. More sustained TGF-b stimulation leads to increased Nab2 expression and its accumulation in the Egr-1-COL1A2 transcriptional complex,
with HDAC1 recruitment, H4 deacetylation,andtranscriptional repression. In sclerodermafibroblasts,defectiveNab2 inductionor function mightresults
in unopposed Egr-1 signaling and target gene transcription. For full explanation, see text (Discussion).
doi:10.1371/journal.pone.0007620.g006
Table 2. Clinical characteristics of scleroderma patients studied.
Skin biopsy samples Age (years) Sex Disease duration (years) Modified Rodnan skin score (1–51)
Scleroderma 1 43 M 0.1 24
Scleroderma 2 29 F 2.2 29
Scleroderma 3 54 F 11.0 4
Scleroderma 4 64 F 20.0 2
Scleroderma 5 63 M 13.0 7
Scleroderma 6 43 F 0.6 24
M, male; F, female.
doi:10.1371/journal.pone.0007620.t002
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resulted in increased Egr-1 activity [13,14,35]. We show here that
TGF-b stimulated the expression of Nab2 in normal fibroblasts.
This response was delayed compared to Egr-1, and was abolished
by an inhibitor of MEK1, indicating that it was mediated via a
MAP kinase signaling pathway.
The in vivo functions of Nab2 are incompletely understood. In
vascular cells, Nab2 repressed the Egr-1-mediated stimulation of
PDGF, TGF-b, tissue factor and PPAR-c transcription
[34,36,37,38,39,40], and inhibited angiogenic responses in vivo
[41,42]. However, it has been shown that Nab2 can also serve to
positively modulate Egr-1-dependent transcription, for example
enhancing rather than repressing the Egr-1-induced stimulation of
Fas ligand expression [21]. The present studies reveal a novel
physiological function for Nab2 in the regulation of fibrogenesis.
While loss of fibroblast Nab2 was accompanied by constitutive
Egr-1 activity that could be partially rescued by ectopic Nab2, in
addition to elevated collagen gene expression and enhanced TGF-
b responses, ectopic Nab2 abrogated the stimulation of fibrotic
responses such as collagen production and myofibroblast differ-
entiation induced by TGF-b. In previous studies, mice deleted for
Nab2 appeared to have no obvious phenotype, whereas mice
lacking both Nab1 and Nab2 developed peripheral neuropathy
and abnormalities in skin development, and suffered from early
lethality [17,43,44]. While these observations suggest functional
redundancy between Nab1 and Nab2, we found here that Nab2
null mice showed excessive collagen accumulation in the dermis,
and explanted Nab2-null fibroblasts in vitro showed both
constitutively elevated Egr-1 transcriptional activity that could be
normalized with ectopic Nab2, and elevated collagen synthesis,
suggesting an important biological role for Nab2 in regulating Egr-
1-dependent fibrogenesis.
It is worth noting that not all TGF-b-induced responses are
abrogated by Nab2. Indeed, transcriptional profiling analysis using
DNA microarrays indicated that the expression of multiple TGF-
b- target genes such as PLOD2 and SMAD7, and few more in
TGF-b-stimulated skin fibroblasts could not be inhibited by
ectopic Nab2 (Bhattacahryya S et al., Ms. in preparation). A
previous study showed that for selected Egr-1 target genes Nab2
was capable of serving as a coactivator rather than repressor for
Egr-1-dependent transcription [21].
Nab2 interacts with members of the NuRD histone deacetylase
complex [27,28,29,30,31,32]. The present results indicate that
repression of TGF-b responses by ectopic Nab2 was associated
with recruitment of both HDAC1 and CHD4 to the COL1A2
promoter, and reduced local histone H4 acetylation. Furthermore,
dominant negative mutant CHD4 abrogated the inhibitory effect
of ectopic Nab2 on Egr-1 activity. We showed previously that
TGF-b induced the recruitment of p300 to the COL1A2
promoter, resulting in histone H4 hyperacetylation [45]. Based
Figure 7. Elevated Nab2 expression in scleroderma skin biopsies. Lesional skin biopsies were obtained from patients with scleroderma
(n=6) and healthy controls (n=3), and processed for immunohistochemistry as described under Methods. A. Nab2 expression. Skin biopsies from
healthy controls (a, b, e) and scleroderma patients (c, d, f, g, h–l). Original magnification6100(a, h),6400 (b, d, i),6630 (c, e, f, j, k, l). Note uniformly
intense Nab2 nuclear immunoreactivity in epithelial cells in scleroderma skin biopsies (h, i, l), as well as in perifollicular and periglandular (c, d, g)
epithelial cells and vascular endothelial cells (f, j), compared to weak and variable Nab2 expression seen in occasional dermal fibroblasts (k, l).
Representative photomicrographs; similar immunostaining pattern was observed in all six scleroderma skin biopsies. B. Phospho-Smad2 (a–d) or Egr-
1 (e–h) expression. Nuclei are counterstained with hematoxylin (blue). Note strong immunostaining in dermal fibroblasts in scleroderma (d, h) skin
biopsies compared to healthy controls (b, f).
doi:10.1371/journal.pone.0007620.g007
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Nab2 might interfere with p300 function or H4 histone acetylation
at the COL1A2 locus by recruiting HDAC1, thereby inhibiting
COL1A2 transcription. Sustained TGF-b stimulation might result
in a relative imbalance between Nab2 and Egr-1 favoring the
former, resulting in inhibition of selected Egr-1-dependent genes.
This notion is illustrated schematically in Fig. 7.
We have shown that Egr-1 expression was up-regulated in
scleroderma skin biopsies [11]. Strong Egr-1 staining was localized
primarily to fibroblastic cells within the reticular dermis,
presumably reflecting activity of TGF-b in the fibrotic cellular
milieu. The present results show that while Nab2 expression was
highly elevated in scleroderma skin biopsies, in contrast to Egr-1, it
was localized almost exclusively to the epidermis and epithelial
cells lining dermal appendages, whereas dermal fibroblasts showed
scant Nab2 expression.
In summary, we furnish novel insight into the pathogenesis of
fibrogenesis by showing that the Egr-1 cofactor Nab2 is potently
induced by TGF-b in normal fibroblasts, and it acts in a negative
feedback loop for repressing Egr-1-dependent TGF-b signaling.
We found a marked overexpression of Nab2 in scleroderma skin
biopsies, where Nab2 was localized to epithelial cells, with only
scant expression in fibroblastic cells in the dermis. These findings
suggest that excessive TGF-b activity in the lesional skin results in
Nab2 up-regulation in the epidermis, whereas in dermal
fibroblasts, the primary effector cells responsible for skin fibrosis,
a relative imbalance between Egr-1 and Nab2 expression exists.
The results suggest that Nab2 forms part of a transcriptional
circuitry that normally plays a negative feedback role by
extinguishing acute Egr-1 activity induced by TGF-b, as well as
hypoxia and other stimuli associated with injury and fibrogenesis.
Since inducible Nab2 expression normally appears to be
responsible for restoring basal homeostasis and fibroblasts
quiescence, defective function of the Egr-1/Nab2 self-regulating
activity might play an important role in the pathogenesis of
fibrosis.
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